Skip to main content

Neurodevelopment

1
Pipeline Programs
2
Companies
2
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
1
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

2 companies ranked by most advanced pipeline stage

March Biosciences
March BiosciencesTX - Houston
1 program
1
Neonatal KitPhase 31 trial
Active Trials
NCT02208960Completed2,294Est. Apr 2016
Human BioSciences
Human BioSciencesWV - Martinsburg
1 program
Friendship BenchN/A1 trial
Active Trials
NCT07430826Not Yet Recruiting1,260Est. Dec 2029

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
2027
2028
2029
March BiosciencesNeonatal Kit
Human BioSciencesFriendship Bench

Clinical Trials (2)

Total enrollment: 3,554 patients across 2 trials

Newborn Kit to Save Lives and Brains in Kenya

Start: Nov 2014Est. completion: Apr 20162,294 patients
Phase 3Completed

Building Opportunities for Nurturing Care to Enhance Child Development in Eastern and Southern Africa

Start: Nov 2026Est. completion: Dec 20291,260 patients
N/ANot Yet Recruiting

Phase Legend

PreclinicalLab & animal studies
Phase 1Safety & dosing
Phase 2Efficacy testing
Phase 3Large-scale trials
On MarketApproved & available

Key Insights

1 late-stage (Phase 3) programs, potential near-term approvals
2 companies competing in this space

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.